References
- Harnden D G. The nature of ataxia-telangiectasia: problems and perspectives. Int J Radiat Biol. 1994; 66: S13–S19
- Filipovich A, Specter B D, Frizzera G H, Kersey J H. Immunodeficiency in humans as a risk factor in the development of malignancy. Prev Med. 1980; 9: 252–259
- Kirsch I R. V(D)J recombination and ataxia-telangiectasia: a review. Int J Radial Biol. 1994; 66: S97–S108
- Savitsky K, Bar-Shira A, Gilard S. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 1995; 268: 1749–1753
- Kersey J H, Spector B D, Good R A. Primary immunodeficiency diseases and cancer: the immunodeficiency-cancer registry. Int J Cancer 1973; 12: 333–347
- Kaneko H, Inoue R, Yamada Y, Kasahara K, Takami T, Kondo N. Ataxia telangiectasia syndrome with B cell lymphoma. Clin Genet. 1996; 49: 331–332
- Abadir R, Hakami N. Ataxia telangiectasia with cancer: an indication for reduced radiotherapy and chemotherapy doses. Br J Radiol. 1983; 56: 343–344
- Gotoff S P, Amiromokri E, Liebner E. Ataxia telangiectasia: neoplasia, untoward response to X-irradiation and tuberous sclerosis. Am J Dis Child. 1967; 117: 617–625
- Weyl Ben Arush M, Rosenthal J. Ataxia telangiectasia and lymphoma: an indication for individualized chemotherapy dosing-report of treatment in a highly inbred Arab family. Pediatr Hematol Oncol. 1995; 12: 163–169
- Overberg-Schmidt U S, Wegner R D, Baumgarten E. Low-grade non-Hodgkin's lymphoma after high-grade non-Hodgkin's lymphoma in a child with ataxia teleangiectasia. Cancer 1994; 73: 1522–1525